# OnCo record athena-mono (trial). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/trials/athena-mono/>
  a schema:MedicalTrial ;
  onco:kind "trial" ;
  schema:identifier "athena-mono", "NCT03522246" ;
  schema:name "ATHENA-MONO / GOG-3020"@en ;
  schema:description "A third PARP inhibitor showed the same pattern: longer disease control after first-line chemotherapy, biggest in tumours with faulty DNA repair."@en ;
  schema:url <https://onco.cc/trials/athena-mono/> ;
  schema:dateModified "2026-09-07"^^xsd:date ;
  schema:citation <https://clinicaltrials.gov/study/NCT03522246>, <https://ascopubs.org/doi/abs/10.1200/JCO.22.01003> ;
  onco:status "positive" ;
  onco:phase "3" ;
  schema:startDate "2018-05-14" ;
  onco:cancers <https://onco.cc/cancers/ovarian/>, <https://onco.cc/cancers/platinum-sensitive-ovarian-cancer/> ;
  onco:technologies <https://onco.cc/technologies/parp-inhibitor/> ;
  onco:targets <https://onco.cc/targets/parp/> ;
  onco:drugs <https://onco.cc/drugs/rucaparib/> ;
  onco:companies <https://onco.cc/companies/clovis-oncology/> ;
  onco:people <https://onco.cc/people/bradley-monk/> .